↓ Skip to main content

Response and resistance to BRAFV600E inhibition in gliomas: Roadblocks ahead?

Overview of attention for article published in Frontiers in oncology, January 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
5 X users

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Response and resistance to BRAFV600E inhibition in gliomas: Roadblocks ahead?
Published in
Frontiers in oncology, January 2023
DOI 10.3389/fonc.2022.1074726
Pubmed ID
Authors

Monica Capogiri, Andrea J. De Micheli, Alvaro Lassaletta, Denise P. Muñoz, Jean-Philippe Coppé, Sabine Mueller, Ana S. Guerreiro Stucklin

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 14%
Researcher 2 14%
Student > Bachelor 1 7%
Unknown 9 64%
Readers by discipline Count As %
Medicine and Dentistry 2 14%
Neuroscience 1 7%
Biochemistry, Genetics and Molecular Biology 1 7%
Unknown 10 71%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 July 2023.
All research outputs
#14,591,631
of 26,228,764 outputs
Outputs from Frontiers in oncology
#3,788
of 23,422 outputs
Outputs of similar age
#189,427
of 494,881 outputs
Outputs of similar age from Frontiers in oncology
#193
of 1,443 outputs
Altmetric has tracked 26,228,764 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 23,422 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 494,881 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 1,443 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.